Adherence to drug therapy in hepatitis C increased total costs in year 1 relative to nonadherent patients, then decreased total costs in year 2.
Jeffrey S. McCombs, PhD
Advertisement
Articles by Jeffrey S. McCombs, PhD
Advertisement
Latest Updated Articles
- Impact of Drug Therapy Duration in Patients With Hepatitis C
Published: November 14th 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Therapeutic Cancer Vaccines: Are We There Yet?
2
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
3
FDA Approves Gazyva for Active Lupus Nephritis
4
Amivantamab Shows 45% Response Rate in Pretreated Head and Neck Cancer: OrigAMI-4 Findings
5
